FDA.reportPublic FDA data

Cell Salts Combination

Manufacturer
Washington Homeopathic Products
Effective date
2018-06-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:55:12

Label at a glance#

ProductCell Salts Combination
Active ingredientTRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, DIBASIC POTASSIUM PHOSPHATE, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, CALCIUM FLUORIDE, SILICON DIOXIDE, POTASSIUM CHLORIDE
Label structure9 sections

Indications and uses

Low energy tonic

Dosage and administration

Adults: Dissolve 2-4 tablets under the tongue 3 times a day. Children: Half the adult dose. Repeat at greater intervals as condition subsides, or as directed by a licensed practitioner.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (HPUS):

Each 100mg tablet contains equal parts of:
Calc flour 6X, Calc phos 6X, Calc sulph 6X, Ferrum phos 6X, Kali mur 6X, Kali phos 6X, Kali sulph 6X, Mag phos 6X, Nat mur 6X,
Nat phos 6X, Nat sulphuricum 6X, Silicea 6X.

The letters “HPUS” indicate that the component in this product is officially monographed in the Homeopathic Pharmacopoeia of the United States.

USES

OTC - PURPOSE SECTION

  • Low energy tonic

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

As with all medications, keep out of reach of children.

INDICATIONS

INDICATIONS & USAGE SECTION

Indications:

Relief of symptoms of boils, pimples and acne.*

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

STOP USE AND ASK DOCTOR

WARNINGS SECTION

If symptoms worsen or persist for more than 7 days, or if pregnant or nursing, consult a licensed practitioner.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults: Dissolve 2-4 tablets under the tongue 3 times a day. Children: Half the adult dose. Repeat at greater intervals as condition subsides, or as directed by a licensed practitioner.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Lactose, Magnesium Stearate, Sodium Starch Glycolate

DO NOT USE

OTC - DO NOT USE SECTION

Do not use if seal is broken.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CELL SALTS COMBINATION 6X

BoxBox

LabelLabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71919-753-362022-03-25C16284748780-19d75b9cf-faca-f424-e053-dadaa90a57ceCELL SALTS COMBINATION
71919-753-362020-01-31C16284748780-19d75b9cf-faca-f424-e053-dadaa90a57ceCELL SALTS COMBINATION

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71919-75371919-753-36

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
NameUNIIKind
TRIBASIC CALCIUM PHOSPHATE91D9GV0Z28ACTIB
CALCIUM SULFATE ANHYDROUSE934B3V59HACTIB
FERROSOFERRIC PHOSPHATE91GQH8I5F7ACTIB
DIBASIC POTASSIUM PHOSPHATECI71S98N1ZACTIB
POTASSIUM SULFATE1K573LC5TVACTIB
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATEHF539G9L3QACTIB
SODIUM CHLORIDE451W47IQ8XACTIB
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE70WT22SF4BACTIB
SODIUM SULFATE0YPR65R21JACTIB
SODIUM STARCH GLYCOLATE TYPE A CORNAG9B65PV6BIACT
MAGNESIUM STEARATE70097M6I30IACT
LACTOSEJ2B2A4N98GIACT
CALCIUM FLUORIDEO3B55K4YKIACTIB
SILICON DIOXIDEETJ7Z6XBU4ACTIB
POTASSIUM CHLORIDE660YQ98I10ACTIB

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
db0c47c0-d7a7-13f3-e053-2a95a90aadcb6dc89102-27ca-4970-e053-2a91aa0af4082022-03-25WarningsExact identifier
spl set id: 6dc89102-27ca-4970-e053-2a91aa0af408

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.